本页面由Tiger Trade Technology Pte. Ltd.提供服务

Amneal Pharmaceuticals, Inc.

19.72
-0.3150-1.57%
成交量:78.79万
成交额:1,559.38万
市值:62.89亿
市盈率:41.00
高:20.15
开:20.14
低:19.66
收:20.03
52周最高:21.18
52周最低:9.56
股本:3.19亿
流通股本:1.91亿
量比:0.29
换手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):0.4808
每股收益(LYR):0.2200
净资产收益率:613.02%
总资产收益率:8.60%
市净率:190.44
市盈率(LYR):89.61

数据加载中...

2023/11/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/24

重要事件披露

Form 8-K - Current report
2023/10/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/17

重要事件披露

Form 8-K - Current report
2023/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/04

重要事件披露

Form 8-K - Current report
2023/05/20

重要事件披露

Form 8-K - Current report
2023/05/12

重要事件披露

8-K - Current report
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/05

重要事件披露

Form 8-K - Current report
2023/04/17

重要事件披露

8-K - Current report
2023/03/03

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]